Suita Research Center
| Representative | Yasutaka Sumida, Director of the Board, Managing Executive Officer |
|---|---|
| Location | 5-8 Nishi Otabi-cho, Suita, Osaka |
| Number of employees | 419 (As of March 31, 2024) |
FY2023 Results of RC Activities
| Occupational safety and health | Zero injuries with loss of workdays, three injuries without loss of workdays*1 |
|---|---|
| Process safety and disaster prevention | Zero Class A and Class B process safety accidents |
| Environmental protection | Recycling 100% of waste |
*1 Total number for Suita Research Center and Himeji Research Center
In the area of occupational safety and health, there were three injuries without loss of workdays that included heat stroke, a fall during office work, and liquid exposure during an experiment. Some of these incidents could have been avoided with hazard prediction, and we plan to incorporate this in future efforts.
In process safety and disaster prevention, we planned and implemented initial response emergency drills that cover all steps from initial firefighting to reporting and evacuation, overall drills, and joint drills with the fire department. Each year, we change the assumed departments where fire occurs and implement the PDCA cycle to improve our disaster and accident preparedness.
In the area of environmental protection, through our thorough efforts to sort waste, we sustained our 100% waste recycling rate, and in energy saving, we are promoting measures to review our method of operations and update outdated equipment.
We intend to continue promoting RC initiatives in an effort to achieve sustainable and safe research activities.
Participation in New Year’s Ceremony
On January 7, 2024, the Suita Fire Fighting New Year’s Ceremony was held under clear skies at the nearby banks of the Kanzaki River.
For Suita Research Center, it was the first time to participate in this activity in four years since FY2019 due to the COVID-19 pandemic.
Numerous organizations, including fire departments, fire brigades, and corporations, participated in the event, which was observed by a large crowd and involved fire-fighting drone shooting and new vehicles as well as demonstrations of rescue drills performed by firefighters. During the simultaneous water discharge display, our team of four new employees demonstrated the results of their pump operation training guided by firefighters, showing off their skills with impressive agility.
Participating in such events is an excellent opportunity to work with the community in preparation for large-scale disasters, and we plan to continue participating in future events.
GMP*2 activities
SGP plant in Suita Research Center started operation as a GMP controlled plant in 2019. In SGP plant, we manufacture active pharmaceutical ingredients (APIs) of middle molecule drugs for commercial and investigational use. Middle molecule drug is a new modality expected to be applicable for various diseases, due to its high specificity to the target molecule. It is considered to have significant potential in various area.
As a manufacturer of API for this promising modality, we pursue reliable high quality of our products as well as operational safety in the manufacturing plant, so that reliable pharmaceutics can be provided which can be used with peace of mind. We will continuously work for further improvement and stabilization of the quality of our products under compliance of GMP on the basis of our underlying RC activities.
*2 GMP: Good Manufacturing Practice
